8. REFERENCES
LaPar DJ, Crosby IK, Rich JB, et al. A contemporary cost analysis of postoperative morbidity after coronary artery by- pass grafting with and without concomitant aortic valve replacement to improve patient quality and cost-effective care . Ann Thorac Surg 2013;96:1621-7;
Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med. 2001;135(12):1061-1073. doi:10.7326/0003-4819-135-12-200112180-00010;
Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004;291(14):1720-1729. doi:10.1001/jama.291.14.1720;
Villareal RP, Hariharan R, Liu BC, et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 2004;43(5):742-748. doi:10.1016/j.jacc.2003.11.023;
Mariscalco G, Klersy C, Zanobini M, et al. Atrial fibrillation after isolated coronary surgery affects late survival. Circulation. 2008;118(16):1612-1618. doi:10.1161/CIRCULATIONAHA.108.777789;
Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 1993;56(3):539-549. doi:10.1016/0003-4975(93)90894-n;
Asher CR, Miller DP, Grimm RA, Cosgrove DM 3rd, Chung MK.Analysis of risk factors for development of atrial fibrillation early after cardiac valvular surgery. Am J Cardiol. 1998;82(7):892-895. doi:10.1016/s0002-9149(98)00498-6;
Bramer S, van Straten AH, Soliman Hamad MA, Berreklouw E, Martens EJ, Maessen JG. The impact of new-onset postoperative atrial fibrillation on mortality after coronary artery bypass grafting. Ann Thorac Surg. 2010;90(2):443-449. doi:10.1016/j.athoracsur.2010.03.083;
Saxena A, Dinh DT, Smith JA, Shardey GC, Reid CM, Newcomb AE.Usefulness of postoperative atrial fibrillation as an independent predictor for worse early and late outcomes after isolated coronary artery bypass grafting (multicenter Australian study of 19,497 patients). Am J Cardiol. 2012;109(2):219-225. doi:10.1016/j.amjcard.2011.08.033;
Kosmidou I, Chen S, Kappetein AP, et al. New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.J Am Coll Cardiol. 2018;71(7):739-748. doi:10.1016/j.jacc.2017.12.012;
Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation. 1996;94(3):390-397. doi:10.1161/01.cir.94.3.390;
Crystal E, Garfinkle MS, Connolly SS, Ginger TT, Sleik K, Yusuf SS.Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 2004;(4):CD003611. Published 2004 Oct 18. doi:10.1002/14651858.CD003611.pub2;
Maesen B, Nijs J, Maessen J, Allessie M, Schotten U.Post-operative atrial fibrillation: a maze of mechanisms.Europace 2012;14:159-74;
Pinho-Gomes AC, Reilly S, Brandes RP, Casadei B. Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins. Antioxid Redox Signal 2014;20:1268-85;
Antoniades C, Demosthenous M, Reilly S, et al. Myocardial redox state pre- dicts in-hospital clinical outcome after cardiac surgery effects of short-term pre- operative statin treatment. J Am Coll Cardiol 2012;59:60-70;
Antoniades C, Bakogiannis C, Leeson P, et al. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling. Circulation 2011;124:335-45;
Kostapanos MS, Liberopoulos EN, Goudevenos JA, et al. Do statins have an anti arrhythmic activity? Cardiovasc Res 2007; 75:10 – 20;
Fauchier L, Clementy N, Babuty D. Statin therapy and atrial fibrillation: systematic review and updated meta-analysis of published randomized controlled trials. Curr Opin Cardiol. 2013;28(1):7-18. doi:10.1097/HCO.0b013e32835b0956;
Kuhn EW, Liakopoulos OJ, Stange S, et al. Preoperative statin therapy in cardiac surgery: a meta-analysis of 90,000 patients. Eur J Cardiothorac Surg 2014;45:17-26;
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med . 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097;
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics . 1977;33(1):159-174;
Higgins J, Altman D, Sterne. Chapter 8: Assessing risk of bias in included studies. In: Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 ed. The Cochrane Collaboration. https://handbook-5-1.cochrane.org/ 2011;
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med . 2002;21(11):1539-1558. doi:10.1002/sim.1186;
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ . 2003;327(7414):557-560. doi:10.1136/bmj.327.7414.557;
Allah EA, Kamel EZ, Osman HM, et al. Could Short-Term Perioperative High-Dose Atorvastatin Offer Antiarrhythmic and Cardio-Protective Effects in Rheumatic Valve Replacement Surgery?. J Cardiothorac Vasc Anesth. 2019;33(12):3340-3347. doi:10.1053/j.jvca.2019.05.013;
Baran Ç, Durdu S, Dalva K, et al. Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: a randomized, controlled trial. Stem Cell Rev Rep. 2012;8(3):963-971. doi:10.1007/s12015-011-9321-z;
Billings FT 4th, Hendricks PA, Schildcrout JS, et al. High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial. JAMA. 2016;315(9):877-888. doi:10.1001/jama.2016.0548
Dehghani MR, Kasianzadeh M, Rezaei Y, Sepehrvand N. Atorvastatin Reduces the Incidence of Postoperative Atrial Fibrillation in Statin-Naive Patients Undergoing Isolated Heart Valve Surgery: A Double-Blind, Placebo-Controlled Randomized Trial. J Cardiovasc Pharmacol Ther. 2015;20(5):465-472. doi:10.1177/1074248414564869;
Ji Q, Mei Y, Wang X, et al. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting . Circ J. 2009;73(12):2244-2249. doi:10.1253/circj.cj-09-0352:
Mannacio VA, Iorio D, De Amicis V, Di Lello F, Musumeci F.Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. J Thorac Cardiovasc Surg. 2008;136(6):1541-1548. doi:10.1016/j.jtcvs.2008.06.038
Osmanovic E, Ostojic M, Avdic S, et al. Pharmacological Prophylaxis of Atrial Fibrillation After Surgical Myocardial Revascularization. Med Arch. 2019;73(1):19-22. doi:10.5455/medarh.2019.73.19-22;
Park JH, Shim JK, Song JW, Soh S, Kwak YL. Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo-controlled trial. Intensive Care Med. 2016;42(9):1398-1407. doi:10.1007/s00134-016-4358-8
Patti G, Chello M, Candura D, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation. 2006;114(14):1455-1461. doi:10.1161/CIRCULATIONAHA.106.621763;
Song YB, On YK, Kim JH, et al. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery. Am Heart J. 2008;156(2):373.e9-373.e3.73E16. doi:10.1016/j.ahj.2008.04.020;
Spadaccio C, Pollari F, Casacalenda A, et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. J Cardiovasc Pharmacol. 2010;55(1):30-38. doi:10.1097/FJC.0b013e3181c37d4d
Sun Y, Ji Q, Mei Y, et al. Role of preoperative atorvastatin administration in protection against postoperative atrial fibrillation following conventional coronary artery bypass grafting. Int Heart J. 2011;52(1):7-11. doi:10.1536/ihj.52.7;
Vukovic PM, Maravic-Stojkovic VR, Peric MS, et al. Steroids and statins: an old and a new anti-inflammatory strategy compared.Perfusion. 2011;26(1):31-37. doi:10.1177/0267659110385607;
Zheng Z, Jayaram R, Jiang L, et al. Perioperative Rosuvastatin in Cardiac Surgery. N Engl J Med. 2016;374(18):1744-1753. doi:10.1056/NEJMoa1507750;
Soucier RJ, Mirza S, Abordo MG, et al. Predictors of conversion of atrial fibrillation after cardiac operation in the absence of class I or III antiarrhythmic medications. Ann Thorac Surg. 2001;72(3):694-698. doi:10.1016/s0003-4975(01)02817-x;
Lee JK, Klein GJ, Krahn AD, et al. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study . Am Heart J. 2000;140(6):871-877. doi:10.1067/mhj.2000.111104;
Liakopoulos OJ, Kuhn EW, Hellmich M, et al. Statin Recapture Therapy before Coronary Artery Bypass Grafting Trial: Rationale and study design of a multicenter, randomized, double-blinded controlled clinical trial. Am Heart J. 2015;170(1):46-54.e542. doi:10.1016/j.ahj.2015.04.015;
Kuhn EW, Slottosch I, Wahlers T, Liakopoulos OJ. Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database Syst Rev 2015;8: CD008493.